Item Type | Name |
Academic Article
|
Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
|
Academic Article
|
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.
|
Academic Article
|
Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
|
Academic Article
|
Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
|
Academic Article
|
Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
|
Academic Article
|
High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
|
Academic Article
|
Interaction of high molecular weight kininogen binding proteins on endothelial cells.
|
Academic Article
|
Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
|
Academic Article
|
The bradykinin-forming cascade and its role in hereditary angioedema.
|
Academic Article
|
Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
|
Concept
|
Factor XI
|
Concept
|
Factor XIa
|
Concept
|
Factor XII Deficiency
|
Concept
|
Factor XIIa
|
Concept
|
Factor VII
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Factor XI Deficiency
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Factor XII
|
Concept
|
Nerve Growth Factor
|
Concept
|
Factor IX
|
Concept
|
Stem Cell Factor
|
Concept
|
Factor VIIa
|
Concept
|
Brain-Derived Neurotrophic Factor
|
Academic Article
|
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
|
Academic Article
|
Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.
|
Academic Article
|
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
|
Academic Article
|
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
|
Academic Article
|
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
|
Academic Article
|
The complement and contact activation systems: partnership in pathogenesis beyond angioedema.
|
Academic Article
|
Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
|
Academic Article
|
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
|
Academic Article
|
The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
|
Academic Article
|
Mediators of urticaria and angioedema.
|
Academic Article
|
Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
|
Academic Article
|
The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
|
Academic Article
|
The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation.
|
Academic Article
|
Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
|
Academic Article
|
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
|
Academic Article
|
Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
|
Academic Article
|
Association of factor XI and high molecular weight kininogen in human plasma.
|
Academic Article
|
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
|
Academic Article
|
Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response.
|
Academic Article
|
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
|
Academic Article
|
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
|
Academic Article
|
Studies of the activation and inhibition of the plasma kallikrein-kinin system.
|
Academic Article
|
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.
|
Academic Article
|
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
|
Academic Article
|
Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor.
|
Academic Article
|
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.
|
Academic Article
|
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE.
|
Academic Article
|
Purification and further characterization of human mononuclear cell histamine-releasing factor.
|
Academic Article
|
Relationship of Hageman factor activation to the formation of bradykinin in humans: a historical perspective.
|
Academic Article
|
Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme.
|
Academic Article
|
Human Hageman factor and its fragments.
|
Academic Article
|
Kinin formation: mechanisms and role in inflammatory disorders.
|
Academic Article
|
The coagulation-kinin pathway of human plasma.
|
Academic Article
|
The effect of C1 inhibitor upon Hageman factor autoactivation.
|
Academic Article
|
The IgE-dependent release of a Hageman factor cleaving factor from human lung.
|
Academic Article
|
Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin.
|
Academic Article
|
Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
|
Academic Article
|
Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.
|
Academic Article
|
Plasma inhibitors of the components of the fibrinolytic pathway in man.
|
Academic Article
|
Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin.
|
Academic Article
|
A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
|
Academic Article
|
The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
|
Academic Article
|
The use of isoelectric focusing to study components of the human plasma kinin-forming system.
|
Academic Article
|
Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
|
Academic Article
|
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
|
Academic Article
|
The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
|
Academic Article
|
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
|
Academic Article
|
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
|
Academic Article
|
Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
|
Academic Article
|
Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
|
Academic Article
|
Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
|
Academic Article
|
Initiation of contact activation of human plasma.
|
Academic Article
|
The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
|
Academic Article
|
The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein.
|
Academic Article
|
Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).
|
Academic Article
|
Activation of the classical pathway of complement by Hageman factor fragment.
|
Academic Article
|
Autoactivatability of human Hageman factor (factor XII).
|
Academic Article
|
Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.
|
Academic Article
|
Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
|
Academic Article
|
Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells.
|
Academic Article
|
Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
|
Academic Article
|
Inhibition of activated factor XII by antithrombin-heparin cofactor.
|
Academic Article
|
Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
|
Academic Article
|
Activation of factor XI in plasma is dependent on factor XII.
|
Academic Article
|
Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
|
Academic Article
|
Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells.
|
Academic Article
|
Intrinsic coagulation, thrombosis, and bleeding.
|
Academic Article
|
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
|
Academic Article
|
Interactions of factor XII with platelets and endothelial cells.
|
Academic Article
|
Binding of activation of kinin-forming proteins on vascular endothelial cells.
|
Academic Article
|
The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation.
|
Academic Article
|
An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23)
|
Academic Article
|
Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.
|
Academic Article
|
Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
|
Academic Article
|
Bradykinin formation. Plasma and tissue pathways and cellular interactions.
|
Academic Article
|
Kinins, airway obstruction, and anaphylaxis.
|
Academic Article
|
Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin.
|
Academic Article
|
Bradykinin-mediated diseases.
|
Academic Article
|
The bradykinin-forming cascade: a historical perspective.
|
Academic Article
|
Neurotropin promotes NGF signaling through interaction of GM1 ganglioside with Trk neurotrophin receptor in PC12 cells.
|
Academic Article
|
Nomenclature of factor XI and the contact system.
|
Academic Article
|
Protease activity in single-chain prekallikrein.
|
Academic Article
|
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
|
Academic Article
|
Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen.
|
Academic Article
|
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
|
Academic Article
|
Activation of the plasma kinin forming cascade along cell surfaces.
|
Academic Article
|
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
|
Academic Article
|
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.
|
Academic Article
|
Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor.
|